drugset / Trial / NCT00470821
Oral Melatonin in Critically Ill High-risk Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
Sleep disruptions are extremely common in high-risk critically ill patients. The investigators want to analyse oral melatonin potentialities as a sedative and a free-radicals scavenger for critically ill patients, and secondarily for preventing Delirium during their ICU stay and post-traumatic stress disorders after ICU discharge.
Timeline
- Start
- 2007-05
- Primary completion
- 2010-04
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Melatonin | Small molecule | 3 mg | Oral |
Indications
No indication recorded.